Mody R, Meyers J, Yu M, Levine J, Davis KL. Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the U.S. Poster presented at the 2021 Virtual American Diabetes Association 81st Scientific Session; June 25, 2021.
Wu B, Morland K, Classi P, Sketch MR, Nelson A, Goyal RK, Davis KL, Oudiz R. Economic burden of patients with pulmonary arterial hypertension prior to initiation of treprostinil: a retrospective analysis of US claims. Poster presented at the ATS International 2021 Conference; May 14, 2021.
Poirrier J-E, Nagar S, Meyers J, Glasser L, Jabbour S. Incidence of herpes zoster in patients with type 2 diabetes and consequences for treatment. Poster presented at the 2020 American Diabetes Association 80th Virtual Scientific Sessions; June 13, 2020. Chicago, IL.
Margrey M, Yi E, Wolin D, Price M, Chirila C, Davenport E, Park Y. Recognition of inflammatory back pain by US healthcare providers and barriers to specialist referral. Poster presented at the 2019 ACR/ARP Annual Meeting; November 10, 2019. Atlanta, GA.
Vass C, Bywall KS, Payne K. Understanding Swedish preferences for a stratified approach to treatment of rheumatoid arthritis with biologics: comparing patients and the public. Poster presented at the Nordic Health Economists Study Group (NHESG) 2018 Annual Meeting; August 2018. Tromso, Norway.
Pladevall M, Zografos L, Tatt I, Napalkov P, Andrews E, Perez-Gutthann S. Feasibility evaluation for a rituximab utilization study to be conducted in infusion centers. Poster presented at the 29th International Conference on Pharmacoepidemiology; August 2013.
Launois R, Le Moine JG, Huynh MT. Mixed treatment comparison, cost-effectiveness and budget impact analysis in the treatment of rheumatoid arthritis after failure of DMARD therapy: a comprehensive decision analytical modelling. Poster presented at the International Society for Pharmacoeconomics and Outcome Research 17th Annual International Meeting; June 2, 2012. Washington, DC.
Hollis K, Calingaert B, Gilligan TM, Sweeney C, Price M, Perez-Gutthann S, Andrews E. Quinolones REMS evaluation surveys. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 18, 2011. Chicago, IL.
Nelson LM, McLeod LD, Mordin MM, Farr J, Cole BJ, Uddin S, Engelhart L. Psychometric evaluation of the Knee Injury and Osteoarthritis Outcome Score (KOOS) subscales for patients with articular cartilage lesions of the knee using pilot study data of the Cartilage Autograft Implantation System (CAIS). Poster presented at the 9th World Congress of the International Cartilage Repair Society; September 2010.
Johannes C, Le TK, Zhou X, Johnston J, Dworkin R. Treatment seeking behavior of adults with chronic lower back pain and chronic osteoarthritis pain: descriptive results from a population survey. Poster presented at the 29th Annual Scientific Meeting of the American Pain Society; May 2010.
Cowell W, Amonkar M, Cooper A, Earnshaw SR, Beard SM, Lynch N, Middelhoven H. Ibandronate vs. alendrolate: a cost-effectiveness analysis using persist results. Poster presented at the 2006 American College of Rheumatology Scientific Meeting; November 2006.
Johannes CB, Zhao S, Shibata A, Schneider G, Wallis W, Walker A. Propensity score analysis in balancing underlying disease severity among rheumatic disease patients treated with etanercept or another DMARD. Poster presented at the American College of Rheumatology Annual Scientific Meeting; 2004.
Williams VS, Smith MY, Fehnel SE. The validity and utility of bpi interference measures addressing the impact of pain. Poster presented at the Annual International Society for Quality of Life Research (ISOQOL) Conference; November 2003.
van der Heijde D, Dougados M, DeMuro-Mercon CJ, Melian A, Watson DJ. Validation of the ankylosing spondylitis quality of life questionnaire (ASQoL). Poster presented at the 67th Annual Scientific Meeting of the American College of Rheumatology; 2003.
Johannes CB, Schneider G, Aygun AC, L'Italien GJ, Viveash D, Wallis WJ. Time to first disease modifying anti-rheumatic drug therapy (DMARD) among rheumatic disease patients in a population based study. Poster presented at the American College of Rheumatology Annual Scientific Meeting; 2003.
Cannuscio CC, Genovese M, DeMuro-Mercon CJ, Cai B, Holmes R, Gottesdiener KM. Markers of cardiovascular risk in patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Poster presented at the 67th Annual Scientific Meeting of the American College of Rheumatology; 2003.